Related Experiment Video
Updated: Aug 14, 2026

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
Published on: February 24, 2014
DNA repair gene polymorphisms affect cytotoxicity in the National Cancer Institute Human Tumour Cell Line Screening
D B Yarosh1, A Peña, D A Brown
1AGI Dermatics, Freeport, NY 11520, USA. danyarosh@agiderm.com
Genetic variations in DNA repair genes influence cancer drug sensitivity. Certain polymorphisms, like XRCC1 R399Q, significantly increase sensitivity, highlighting DNA repair
Area of Science:
- Genetics
- Molecular Biology
- Pharmacology
Background:
- Polymorphisms in DNA repair genes are linked to disease risk, but epidemiological findings are inconsistent.
- Understanding these genetic variations is crucial for personalized cancer treatment.
Purpose of the Study:
- To investigate the impact of polymorphisms in DNA repair, regulatory, and signaling genes on the cytotoxic sensitivity of cancer cell lines.
- To correlate specific gene variants with drug response for improved anticancer drug screening.
Main Methods:
- Examined polymorphisms in base and nucleotide excision-repair genes (e.g., TP53, ERCC2, OGG1, XRCC1, NOS3) in National Cancer Institute tumor cell lines.
- Assessed cytotoxic sensitivity across a range of anticancer drugs.
- Measured 8-oxo-guanine DNA repair in cell lines with varying OGG1 genotypes.
Main Results:
- Heterozygous TP53 P72R and ERCC2 D312N genotypes showed increased sensitivity.
- Homozygous-variant OGG1 S326C and NOS3 g.-786T>C genotypes were most sensitive.
- XRCC1 R399Q homozygous dominant genotype exhibited the greatest sensitization across multiple drugs.
- TP53 P72R heterozygous genotype was depleted, deviating from Hardy-Weinberg equilibrium.
- Cell lines with homozygous-variant OGG1 genotype demonstrated significantly poorer DNA repair capacity.
Conclusions:
- DNA repair gene polymorphisms significantly influence sensitivity to anticancer drugs.
- Correlating polymorphisms with cytotoxicity offers a viable approach to understanding their complex roles, potentially overcoming limitations of epidemiological studies.
- Findings suggest potential for genotype-guided anticancer drug selection.
More Related Videos
06:21Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
05:01Assessment of DNA Double Strand Break Repair Activity Using High-throughput and Quantitative Luminescence-Based Reporter Assays
Published on: June 14, 2024
Related Concept Videos
Nucleotide Excision Repair
Nucleotide Excision Repair
DNA Damage can Stall the Cell Cycle
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
DNA Damage Can Stall the Cell Cycle
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase